News

INL's Nanosafety Laboratory Achieves Prestigious GLP Certification

INL's Nanosafety Laboratory Achieves Prestigious GLP Certification

INL's Nanosafety Laboratory Recognized for Excellence

The Nanosafety Laboratory of the International Iberian Nanotechnology Laboratory (INL) has achieved a notable milestone by gaining recognition from the Portuguese Institute for Quality (IPQ). This certification highlights INL's adherence to the rigorous compliance standards set by the Organisation for Economic Co-operation and Development (OECD) Principles of Good Laboratory Practices (GLP).

Significance of GLP Certification

This GLP certification demonstrates INL's unwavering commitment to conducting safe and trustworthy nanotechnology research. It underscores the credibility and quality of its testing procedures, crucial for the advancement of the field. Following a thorough inspection conducted recently, INL's Nanosafety Laboratory has proven to meet the highest standards in testing and evaluating nanomaterials. This is particularly important for applications in various sectors, including industrial and agri-food industries.

Commitment to Safety and Innovation

At INL, the focus is on ensuring that the development and utilization of nanomaterials meet strict safety regulations. The laboratory is engaged in essential toxicity testing processes that are vital for maintaining safety standards. Specific GLP certified activities include:

  • Biomarker Quantification using Multiplex Systems: Delivering precise analysis of biological markers for accurate safety assessments.
  • Intracellular Reactive Oxygen Species (ROS) Measurement: Assessing oxidative stress to evaluate the toxicological impact of nanomaterials.
  • Cytotoxicity Testing using Resazurin Assay: This measures cell viability to determine the adverse effects of nanomaterials.

Global Recognition and Future Endeavors

As a result of obtaining GLP certification, INL's reputation as a leading entity in nanotechnology research has been significantly bolstered. This achievement enhances opportunities for international collaboration with prominent research institutions and industrial stakeholders. Assurance that INL’s data complies with rigorous global regulatory standards allows companies relying on nanomaterial safety evaluations to access markets more swiftly.

Leading the Way in Nanotechnology

The global demand for safe and effective nanomaterials is increasing, and INL is strategically positioned to support various industries with its state-of-the-art testing methodologies. This certification not only affirms the laboratory’s dedication to data integrity but also enhances the commitment to risk-based management while upholding top-notch safety standards.

Collaborative Efforts Behind the Success

The successful certification process was the outcome of extensive teamwork across INL. Significant contributions came from different research groups, including Alfaro-Moreno’s Research Group and Espiña’s Research Group, as well as support from the Department of Business and Strategic Relations and the Coordination & Quality Management Unit. Their collective efforts have played a pivotal role in driving innovation forward in nanomaterial safety testing.

About the International Iberian Nanotechnology Laboratory

The International Iberian Nanotechnology Laboratory (INL) is an intergovernmental organization dedicated to addressing critical societal challenges through the lens of nanotechnology research and innovation. Covering various sectors, ranging from health to energy and food, INL emphasizes crafting sustainable solutions to benefit future generations.

Frequently Asked Questions

What is GLP certification and why is it important?

GLP certification is a quality standard for laboratories engaged in non-clinical safety studies. It is crucial as it ensures the reliability and integrity of data generated in research.

How does INL ensure the safety of nanomaterials?

INL conducts thorough toxicity tests and follows strict safety protocols to ensure that nanomaterials meet safety requirements before their application in various fields.

Which activities in the Nanosafety Laboratory are GLP certified?

Key GLP certified activities include biomarker quantification, intracellular ROS measurement, and cytotoxicity testing using advanced assays.

What does the GLP certification mean for INL's research collaborations?

The GLP certification enhances INL's credibility and opens new avenues for international collaborations, ensuring that data meets global regulatory standards.

How does INL's work contribute to societal challenges?

INL addresses significant societal challenges by applying nanotechnology in areas such as health, environment, and energy, striving for sustainable solutions that cater to current and future needs.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

PotlatchDeltic Reveals Tax Implications for 2024 Shareholder Dividends

Updated Category News Views 247

PotlatchDeltic Reveals Dividend Tax Treatment for 2024 PotlatchDeltic Corporation (Nasdaq: PCH) is stepping into the spotlight by announcing the tax treatment for its anticipated dividend distributions throughout the year. As a prominent player in the real estate investment sector, this announcement brings clarity to investors regarding how dividends will be categorized...

Continue Reading
Beyond Air Secures $3.25 Million from Warrant Exercises

Updated Category News Views 158

Beyond Air's Strategic Moves to Boost Capital Beyond Air, Inc. (NASDAQ: XAIR), a leading medical device and biopharmaceutical company, is making waves in the financial realm. Focused on the innovative use of nitric oxide (NO) to enhance patient care, Beyond Air has announced the immediate exercise of certain outstanding warrants, aiming to generate approximately $3.25...

Continue Reading
Dr. Sven Kili Joins Saisei Ventures as New Partner

Updated Category News Views 194

Saisei Ventures Welcomes Dr. Sven Kili as Partner Saisei Ventures, a prominent investment firm focused on the advancement of biotechnology and therapeutic innovations, has announced an exciting new chapter in its journey. Dr. Sven Kili, MD, has been appointed as a partner, marking a significant addition to the team's leadership. Dr. Kili, who played an advisory role since...

Continue Reading
MangoRx Unveils Innovative Tirzepatide Tablet for Weight Loss

Updated Category News Views 192

Mangoceuticals, Inc. (NASDAQ: MGRX) launched its new oral Tirzepatide tablet, TRIM, back in 2024 at a steep price of $399 per month. Traders noticed this shift towards a convenient alternative to traditional injectables and were already debating the long-term implications on sales and market share. TRIM's Role: A Game Changer for Weight Management? Tirzepatide has made...

Continue Reading
Mama’s Creations Q2 FY2025 Earnings Call Announcement

Updated Category News Views 77

Mama’s Creations to Host Earnings Call for Second Quarter FY2025 Mama’s Creations, Inc. (NASDAQ: MAMA), a leading national marketer and manufacturer of fresh deli prepared foods, is preparing to announce its financial results for the fiscal second quarter, which ended on July 31. The earnings call is scheduled to take place after the market closes on September 10....

Continue Reading